Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: A randomized controlled trial
Antineoplastic Combined Chemotherapy Protocols
Chemotherapy-induced amenorrhea is common with ensuing bone loss at the spine and hip. Pamidronate prevented bone loss at the spine and hip and was well tolerated.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency